Uncontrolled study of post-exposure prophylaxis for influenza by peramivir
Phase of Trial: Phase I/II
Latest Information Update: 16 Jun 2016
Price : $35 *
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 15 Jun 2016 Status changed from recruiting to discontinued.
- 11 Aug 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 09 Oct 2014 New trial record